SalvaRx Group Plc Company Profile (LON:3LEG)

About SalvaRx Group Plc (LON:3LEG)

SalvaRx Group Plc logoSalvaRx Group plc, formerly 3Legs Resources plc, is an investing company. The Company is engaged in drug discovery and development, focused on immune-oncology. The Company's segment is appraisal of investment targets meeting the Company's investment policy. The Company is focused on evaluation and assessment of investment opportunities in line with the investment policy. Its product is IMM60. It expects the study to evaluate approximately three treatment groups: a control arm using the standard of care (an anti-programmed death (PD)-1 therapy), a trial arm using iOX Therapeutics Ltd's drug (IMM60), and a third arm that will test the combination of IMM60 and an anti-PD1 therapy. 3Legs Management Services US LLC is the subsidiary of the Company.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: LON:3LEG
  • CUSIP: N/A
  • Web: www.3legsresources.com/
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Profitability:
  • Return on Equity: -168.36%
  • Return on Assets: -64.33%
 

Frequently Asked Questions for SalvaRx Group Plc (LON:3LEG)

What is SalvaRx Group Plc's stock symbol?

SalvaRx Group Plc trades on the London Stock Exchange (LON) under the ticker symbol "3LEG."

Who are some of SalvaRx Group Plc's key competitors?

Who are SalvaRx Group Plc's key executives?

SalvaRx Group Plc's management team includes the folowing people:

  • Kamlesh Rameshbhai Parmar, Chief Executive Officer, Executive Director
  • Frances Morris-Jones, Business Development Director
  • Alexander Fraser, Chief Financial Officer, Director
  • Richard J. Armstrong, Non-Executive Chairman of the Board
  • Timothy John Crommelin Eggar, Non-Executive Independent Chairman of the Board
  • Gregory H. Bailey M.D., Non-Executive Director
  • James Mellon, Non-Executive Director

How do I buy SalvaRx Group Plc stock?

Shares of SalvaRx Group Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is SalvaRx Group Plc's stock price today?

One share of SalvaRx Group Plc stock can currently be purchased for approximately GBX 0.32.


MarketBeat Community Rating for SalvaRx Group Plc (LON 3LEG)
Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  89 (Vote Outperform)
Underperform Votes:  46 (Vote Underperform)
Total Votes:  135
MarketBeat's community ratings are surveys of what our community members think about SalvaRx Group Plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for SalvaRx Group Plc (LON:3LEG) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for SalvaRx Group Plc (LON:3LEG)
Price Target History for SalvaRx Group Plc (LON:3LEG)
Analysts' Ratings History for SalvaRx Group Plc (LON:3LEG)
Show:
DateFirmActionRatingPrice TargetDetails
2/2/2016Northland SecuritiesReiterated RatingCorporateView Rating Details
(Data available from 10/21/2015 forward)

Earnings

Earnings History for SalvaRx Group Plc (LON:3LEG)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for SalvaRx Group Plc (LON:3LEG)
Current Year EPS Consensus Estimate: $-3.00 EPS

Dividends

Dividend History for SalvaRx Group Plc (LON:3LEG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for SalvaRx Group Plc (LON:3LEG)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for SalvaRx Group Plc (LON:3LEG)
Latest Headlines for SalvaRx Group Plc (LON:3LEG)
Source:
Loading headlines, please wait.

Social

Social activity is not available for this stock.

Chart

SalvaRx Group Plc (3LEG) Chart for Saturday, October, 21, 2017

This page was last updated on 10/21/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.